Management of acute right ventricular failure in the intensive care unit

Current Heart Failure Reports

Volumn 9, Issue 3, 2012, Pages 228-235

  Green, Eric M ^a   Givertz, Michael M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Critical care; Heart failure; Pulmonary hypertension; Right ventricle

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; MILRINONE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN; CARDIOTONIC AGENT; VASODILATOR AGENT;

ACUTE HEART FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASSISTED CIRCULATION; ASSISTED VENTILATION; BALLOON ATRIAL SEPTOSTOMY; CARDIAC PATIENT; CARDIOVASCULAR PROCEDURE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONGENITAL HEART DISEASE; ENDOCARDITIS; EXTRACORPOREAL OXYGENATION; HEART LEFT VENTRICLE FAILURE; HEART RHYTHM; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE INFARCTION; HEART RIGHT VENTRICLE OVERLOAD; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; LUNG EMBOLISM; PATHOPHYSIOLOGY; RIGHT VENTRICULAR ASSIST DEVICE; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; ACUTE DISEASE; ARTIFICIAL VENTILATION; DRUG EFFECT; HEART ASSIST DEVICE; HEART ATRIUM SEPTUM; HEART FAILURE; HEART PACING; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; INTENSIVE CARE; METHODOLOGY; PHYSIOLOGY; REVIEW; VASCULAR RESISTANCE;

ACUTE DISEASE; ATRIAL SEPTUM; CARDIAC PACING, ARTIFICIAL; CARDIOTONIC AGENTS; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INTENSIVE CARE; RESPIRATION, ARTIFICIAL; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 84871883193     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-012-0104-x     Document Type: Article

References (62)

1. Kagan A. Dynamic responses of the right ventricle following extensive damage by cauterization. Circulation. 1952;5(6):816-23.
2. Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, et al. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol. 2001;37(1):37-43. (Pubitemid 32051716)
3. Goldstein JA, Harada A, Yagi Y, Barzilai B, Cox JL. Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchrony in acute right ventricular dysfunction. J Am Coll Cardiol. 1990;16(1):181-9. (Pubitemid 20217062)
4. ••Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail. 2008;14(10):824-30. Elsevier. Renal dysfunction is a frequent complication of heart failure and is thought to result from decreased renal perfusion and low cardiac output. This paper suggests a role for right ventricular failure and venous congestion, specifically tricuspid regurgitation, in renal dysfunction.
5. Stein PD, Sabbah HN, Anbe DT, Marzilli M. Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertension. Am J Cardiol. 1979;44(6):1050-5. (Pubitemid 10205767)
6. McIntyre KM, Sasahara AA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol. 1971;28(3):288-94.
7. O'Rourke RA, Dell'Italia LJ. Diagnosis and management of right ventricular myocardial infarction. Curr Probl Cardiol. 2004;29 (1):6-47.
8. Lahm T, McCaslin CA, Wozniak TC, Ghumman W, Fadl YY, Obeidat OS, et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol. 2010;56(18):1435-46.
9. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117(11):1436-48. (Pubitemid 351501496)
10. Balanos GM, Talbot NP, Dorrington KL, Robbins PA. Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol. 2003;94(4):1543-51. (Pubitemid 36348834)
11. Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome? Curr Opin Crit Care. 2003;9(1):15-21. (Pubitemid 36157374)
12. Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med. 2003;29(9):1426-34. (Pubitemid 37158027)
13. David M, von Bardeleben RS, Weiler N, Markstaller K, Scholz A, Karmrodt J, et al. Cardiac function and haemodynamics during transition to high-frequency oscillatory ventilation. Eur J Anaesthesiol. 2004;21(12):944-52. (Pubitemid 40288919)
14. Vieillard-Baron A, Charron C, Caille V, Belliard G, Page B, Jardin F. Prone positioning unloads the right ventricle in severe ARDS. Chest. 2007;132(5):1440-6. (Pubitemid 350155997)
15. Sarnoff SJ. Myocardial contractility as described by ventricular function curves; observations on Starling's law of the heart. Physiol Rev. 1955;35(1):107-22.
16. Cohn JN, Guiha NH, Broder MI, Limas CJ. Right ventricular infarction. Clinical and hemodynamic features. Am J Cardiol. 1974;33(2):209-14.
17. Schneider A, Teule G, Groeneveld A. ScienceDirect.com - American Heart Journal - Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J. 1988;116(1):103-12.
18. Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest. 2005;128 (3):1836-52. (Pubitemid 41324483)
19. Ferrario M, Poli A, Previtali M, Lanzarini L, Fetiveau R, Diotallevi P, et al. Hemodynamics of volume loading compared with dobutamine in severe right ventricular infarction. Am J Cardiol. 1994;74 (4):329-33. (Pubitemid 24253468)
20. Dell'Italia LJ, Starling MR, Blumhardt R, Lasher JC, O'Rourke RA. Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation. 1985;72(6):1327-35. (Pubitemid 16126813)
21. Kerbaul F, Rondelet B, Motte S, Fesler P, Hubloue I, Ewalenko P, et al. Effects of norepinephrine and dobutamine on pressure loadinduced right ventricular failure. Crit CareMed. 2004;32(4):1035-40. (Pubitemid 38471527)
22. Chen M, Edward P, Bittner M, Hartmuth B, Davis RD, Van Trigt III P. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg. 1997;63(3):814-21. Elsevier. (Pubitemid 27128706)
23. Levy JH, Bailey JM, Deeb GM. Intravenous milrinone in cardiac surgery. Ann Thorac Surg. 2002;73(1):325-30. (Pubitemid 34084602)
24. Tayama E, Ueda T, Shojima T, Akasu K, Oda T, Fukunaga S, et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg. 2007;6(6):715-9. Oxford University Press. (Pubitemid 350291683)
25. Russ RD, Walker BR. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am J Physiol. 1992;262(3 Pt 2): H743-7.
26. Eichinger MR, Walker BR. Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. Am J Physiol. 1994;267(6 Pt 2):H2413-9.
27. Kwak YL, Lee CS, Park YH, Hong YW. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension. Anaesthesia. 2002;57(1):9-14. (Pubitemid 34116365)
28. Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology. 1984;60(2):132-5. (Pubitemid 14176323)
29. Angle MR, Molloy DW, Penner B, Jones D, Prewitt RM. The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism. Chest. 1989;95(6):1333-7. (Pubitemid 19160168)
30. Le Tulzo Y, Seguin P, Gacouin A, Camus C, Suprin E, Jouannic I, et al. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study. Intensive Care Med. 1997;23(6):664-70. (Pubitemid 27312046)
31. Meldrum DR, Shames BD, Meng X, Fullerton DA, McIntyre RC, Grover FL, et al. Nitric oxide downregulates lung macrophage inflammatory cytokine production. Ann Thorac Surg. 1998;66(2):313-7. (Pubitemid 28410652)
32. Inglessis I, Shin JT, Lepore JJ, Palacios IF, Zapol WM, Bloch KD, et al. Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol. 2004;44(4):793-8. (Pubitemid 39099575)
33. Ardehali A, Hughes K, Sadeghi A, Esmailian F,Marelli D, Moriguchi J, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72(4):638-41. (Pubitemid 32802745)
34. Bradford KK, Deb B, Pearl RG. Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit. J Cardiovasc Pharmacol. 2000;36(2):146.
35. Vizza CD, Rocca GD, Roma AD, Iacoboni C, Pierconti F, Venuta F, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care. 2001;5 (6):355-61. (Pubitemid 34130338)
36. Khazin V, Kaufman Y, Zabeeda D, Medalion B, Sasson L, Schachner A, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth. 2004;18(2):156-9. (Pubitemid 38506861)
37. Christenson J, Lavoie A, O'Connor M, Bhorade S, Pohlman A, Hall JB. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med. 2000;161(5):1443-9. (Pubitemid 30329010)
38. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994;90(6):2780-5. Am Heart Assoc.
39. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol. 1994;24(4):982-8. Elsevier. (Pubitemid 24306408)
40. Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg. 2009;138(6):1417-24.
41. Gordon C, Collard CD, Pan W. Intraoperative management of pulmonary hypertension and associated right heart failure. Curr Opin Anaesthesiol. 2010;23(1):49-56.
42. Sastry BKS, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43(7):1149-53. (Pubitemid 38452588)
43. Trachte AL, Lobato EB, Urdaneta F, Hess PJ, Klodell CT, Martin TD, et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg. 2005;79(1):194-7. discussion194- 7. (Pubitemid 40037471)
44. ••Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1(4):213-9. Persistent pulmonary hypertension and right ventricular dysfunction are risk factors for mortality in endstage heart failure patients after institution of mechanical circulatory support. This paper suggests that PDE5 inhibitors may improve residual pulmonary hypertension and cardiac output after LVAD implantation.
45. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation. 2007;116:1555-62. (Pubitemid 47511419)
46. Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, et al. Phosphodiesterase Type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase Type 5 improves contractility. Circulation. 2007;116:238-48. (Pubitemid 47196559)
47. Love JC, Haffajee CI, Gore JM, Alpert JS. Reversibility of hypotension and shock by atrial or atrioventricular sequential pacing in patients with right ventricular infarction. Am Heart J. 1984;108 (1):5-13. (Pubitemid 14087961)
48. Topol EJ, Goldschlager N, Ports TA, Dicarlo LA, Schiller NB, Botvinick EH, et al. Hemodynamic benefit of atrial pacing in right ventricular myocardial infarction. Ann InternMed. 1982;96(5):594-7. (Pubitemid 12111114)
49. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003;107(18):2287-9. (Pubitemid 36578496)
50. Kahn D. Postinfarct refractory right ventricle: right ventricular exclusion. A possible option to mechanical cardiac support, in patients unsuitable for heart transplant. J Cardiovasc Surg. 2000;41(3):349-55. (Pubitemid 30450000)
51. Hangler HB, Bonatti JO, Antretter H, Mair P, Müller LC. Isolated right ventricular assist for postcardiotomy myocardial infarction. Ann Thorac Surg. 1999;68(6):2326-8. (Pubitemid 30027873)
52. Moazami N, Pasque MK, Moon MR, Herren RL, Bailey MS, Lawton JS, et al. Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transplant. 2004;23(12):1371-5. Elsevier. (Pubitemid 40018159)
53. Furukawa K, Motomura T, Nosé Y. Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device. Artif Organs. 2005;29(5):369- 77. Wiley Online Library. (Pubitemid 41632978)
54. Klima U, Ringes-Lichtenberg S,Warnecke G, Lichtenberg A, Struber M, Haverich A. Severe right heart failure after heart transplantation. A single-center experience. Transplant Int. 2005;18(3):326-32. (Pubitemid 41726897)
55. Berman M, Tsui S, Vuylsteke A, Klein A, Jenkins DP. Lifethreatening right ventricular failure in pulmonary hypertension: RVAD or ECMO? J Heart Lung Transplant. 2008;27(10):1188-9.
56. ••Berman M, Tsui S, Vuylsteke A, Snell A, Colah S, Latimer R, et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg. 2008;86 (4):1261-7. Patients with persistent pulmonary hypertension following pulmonary thromboendarterectomy have a high rate of mortality. This paper reports the successful use of VA-ECMO for complete cardiorespiratory support in aiding their recovery.
57. Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry report 2004. ASAIO J. 2005;51(1):4-10. (Pubitemid 40165243)
58. Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Heart. 1986;55 (5):449-58. (Pubitemid 16122489)
59. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant. 1996;15(1 Pt 1):100-5. (Pubitemid 26056129)
60. Sandoval J, Gaspar J, Pulido T, Bautista E, Martínez-Guerra ML, Zeballos M, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998;32(2):297-304. (Pubitemid 28396475)
61. Rich S, Dodin E, McLaughlin VV. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol. 1997;80(3):369-71. (Pubitemid 27330166)
62. Blanc J, Vouhé P, Bonnet D. Potts shunt in patients with pulmonary hypertension. N Engl J Med. 2004;350(6):623-3. Mass Medical Soc.